Company Profile

Upstate USA Inc (AKA: Upstate Biotechnology Inc~CHEMICON)
Profile last edited on: 5/1/2008      CAGE: 1D7S4      UEI: YX51A34TEM73

Business Identifier: Biological Reagents To Academic, Industrial and Institutional Laboratories
Year Founded
1984
First Award
1985
Latest Award
2004
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

706 Forest Street
Charlottesville, VA 22903
   (434) 975-4300
   dae2s@virginia.edu
   www.upstate.com
Location: Multiple
Congr. District: 05
County: Charlottesville city

Public Profile

In September of 2004, Upstate USA Inc was acquired by Serologicals Corporation (NASDAQ: SERO) .With facilities in Europe and the United States, Upstate Biotechnology manufactures growth factors and related products used in biological research and manufacturing. Products include mammalian cell cultures, condition media, lymphokines, cytoskeletal antibodies, protein antibodies, serum, nitrogens and cytokines

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2004 1 NIH $207,596
Project Title: Novel Tool Compounds for Chromatin Research
1986 1 NIH $50,000
Project Title: Immunoassay & cloning of angiotropins
1985 1 NIH $50,000
Project Title: Novel low-cost food chain for matriculture

Key People / Management

  Sheridan Snyder -- CEO

  Daniel A Engel

  Per-Eri Mansson

  Kwan-Sa You

Company News

There are no news available.